Touchlight Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 159

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $127M

  • Investors
  • 4

Touchlight General Information

Description

Developer of enzymatic DNA technologies designed to enable genetic medicines including viral vector production, mRNA and DNA-based therapies, and vaccines. The company provides contract development and manufacturing services to produce dbDNA as a critical starting material for advanced therapy production and also licenses its technology to partners, providing the healthcare industry with speed, scale, and ability to target genes of large size and complexity.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Morelands and Riverdale Buildings
  • Lower Sunbury Road
  • Hampton TW12 2ER
  • England, United Kingdom
+44 020 0000 0000

Touchlight Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Touchlight Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 15-Sep-2021 $127M 00000 00000 Completed Generating Revenue
4. Later Stage VC 11-Mar-2021 000.00 000.00 00000 Completed Generating Revenue
3. Secondary Transaction - Private 000.00 Completed Generating Revenue
2. Later Stage VC 20-Dec-2017 $6.11M $13.6M 000.00 Completed Generating Revenue
1. Later Stage VC 03-Nov-2014 $7.5M $7.5M 0000 Completed Generating Revenue
To view Touchlight’s complete valuation and funding history, request access »

Touchlight Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 00,000 00.000000 000.00 000.00 000.00 0.000
Preference 000,000 00.000000 0000.00 0000.00 0000.00 00.000
Ordinary 0,000 00.000000 0000.00 0000.00 0000.00 0.000
Ordinary 00,000 00.000000 0000.00 0000.00 0000.00 0.000
Ordinary 00,000 00.000000 000.00 000.00 000.00 0.000
Ordinary 85,628 $0.013769 $65.54 $65.54 $65.54 7.67%
Ordinary 15,269 $0.013769 $53.92 $53.92 $53.92 1.37%
To view Touchlight’s complete cap table history, request access »

Touchlight Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of enzymatic DNA technologies designed to enable genetic medicines including viral vector production, mRNA and
Drug Discovery
Hampton, United Kingdom
159 As of 2024
00000
0000 0000-00-00
0000000000 0 00000

000000

um dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt
0000 000000000
Dusseldorf, Germany
00 As of 0000
0000000000

000000

illum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non pro
0000000000000
Lausanne, Switzerland
00 As of 0000
00.000
00000 00000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Touchlight Competitors (51)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Numaferm Venture Capital-Backed Dusseldorf, Germany 00 0000000000
Adaptyv Bio Venture Capital-Backed Lausanne, Switzerland 00 00.000 00000 00000 00.000
Twist Bioscience Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
Glycotope Formerly VC-backed Berlin, Germany 00 00000 00000000000 00000
Deep Genomics Venture Capital-Backed Toronto, Canada 000 00000 00000000000 00000
You’re viewing 5 of 51 competitors. Get the full list »

Touchlight Patents

Touchlight Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201502645-D0 Method Inactive 17-Feb-2015 0000000000
GB-201415789-D0 Synthesis of dna Inactive 05-Sep-2014 0000000000
GB-201410302-D0 Closed linear dna nanoparticles Inactive 10-Jun-2014
GB-201303913-D0 Synthesis apparatus and method Inactive 05-Mar-2013 00000000
GB-201013153-D0 Primer for production of closed linear dna Inactive 04-Aug-2010 C12P19/34
To view Touchlight’s complete patent history, request access »

Touchlight Executive Team (14)

Name Title Board Seat Contact Info
Jonathan Ohlson Founder, Group Chief Executive Officer & Executive Chairman
Karen Fallen Chief Executive Officer
Alistair Howes Chief Financial Officer
Tommy Duncan Chief Operating Officer, Group Business Development Officer & Chief Business Officer
Anjum Ahmad Chief Accounting Officer & Company Secretary
You’re viewing 5 of 14 executive team members. Get the full list »

Touchlight Board Members (12)

Name Representing Role Since
Birgir Már Ragnarsson Novator Partners Board Member 000 0000
Bradley Theobald Self General Counsel, Chief of Staff & Board Member 000 0000
David Lewis Self Board Member 000 0000
John Dwyer Self Board Member 000 0000
Jonathan Ohlson Touchlight Founder, Group Chief Executive Officer & Executive Chairman 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Touchlight Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Touchlight Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Novator Partners PE/Buyout Minority 000 0000 000000 0
Bridford Group Venture Capital Minority 000 0000 000000 0
Capital Innovators Accelerator/Incubator Minority 000 0000 000000 0
Downing Ventures Venture Capital Minority 000 0000 000000 0
To view Touchlight’s complete investors history, request access »

Touchlight Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Touchlight Aquaculture 27-Jul-2020 00000 0000 Drug Discovery 0000000 0
To view Touchlight’s complete investments history, request access »

Touchlight Subsidiaries (1)

Company Name Industry Location Founded
Touchlight Aquaculture Drug Discovery London, United Kingdom 0000
To view Touchlight’s complete subsidiaries history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »